5.06
price up icon12.69%   0.57
pre-market  시장 영업 전:  5.06  
loading

Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스

pulisher
Dec 04, 2025

Taysha Gene Therapies (TSHA) Upgraded to Buy by Goldman Sachs - GuruFocus

Dec 04, 2025
pulisher
Dec 04, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 7%Still a Buy? - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

Taysha Gene Therapies upgraded at Goldman Sachs on advancing Rett syndrome asset - Seeking Alpha

Dec 04, 2025
pulisher
Dec 04, 2025

Taysha Gene Therapies (TSHA) Receives Buy Rating from Goldman Sa - GuruFocus

Dec 04, 2025
pulisher
Dec 03, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Shares Down 6.5% on Insider Selling - MarketBeat

Dec 03, 2025
pulisher
Dec 03, 2025

How Taysha Gene Therapies Inc. stock reacts to oil prices2025 EndofYear Setup & Technical Confirmation Alerts - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Sukumar Nagendran Sells 110,125 Shares of Taysha Gene Therapies (NASDAQ:TSHA) Stock - MarketBeat

Dec 02, 2025
pulisher
Dec 02, 2025

Taysha Gene Therapies Insider Sold Shares Worth $1,695,906, According to a Recent SEC Filing - marketscreener.com

Dec 02, 2025
pulisher
Dec 01, 2025

Nagendran Sukumar sells Taysha gene therapies (TSHA) shares for $1.69m - Investing.com Canada

Dec 01, 2025
pulisher
Nov 27, 2025

TSHA FY2026 EPS Forecast Raised by Cantor Fitzgerald - MarketBeat

Nov 27, 2025
pulisher
Nov 27, 2025

How analysts rate Taysha Gene Therapies Inc. stock todayQuarterly Portfolio Summary & Safe Capital Growth Trade Ideas - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 20, 2025

Will breakout in Taysha Gene Therapies Inc. lead to full recoveryQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Using Bollinger Bands to evaluate Taysha Gene Therapies Inc.Portfolio Return Report & Growth-Oriented Investment Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Custom watchlist performance reports with Taysha Gene Therapies Inc.2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Taysha Gene Therapies Inc. stock recover after recent dropWeekly Risk Report & Safe Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Taysha Gene Therapies Inc. stock benefits from strong dollarJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Why Taysha Gene Therapies Inc. stock is favored by top institutionsJuly 2025 Technicals & Free Long-Term Investment Growth Plans - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Is Taysha Gene Therapies Inc. (TSHA) One of the Must-Buy Penny Stocks to Buy Now? - MSN

Nov 18, 2025
pulisher
Nov 17, 2025

11 Must-Buy Penny Stocks to Buy Now - Insider Monkey

Nov 17, 2025
pulisher
Nov 17, 2025

Is Taysha Gene Therapies Inc. stock near bottom after declineJuly 2025 Opening Moves & AI Based Buy/Sell Signal Reports - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Can Taysha Gene Therapies Inc. hit a new high this monthTrade Ideas & Weekly High Momentum Picks - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Can Taysha Gene Therapies Inc. stock sustain institutional interestJuly 2025 Retail & Short-Term Trading Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Candlestick signals on Taysha Gene Therapies Inc. stock todayJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Detecting support and resistance levels for Taysha Gene Therapies Inc.Market Performance Summary & Real-Time Stock Entry Alerts - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Will a bounce in Taysha Gene Therapies Inc. offer an exitJuly 2025 Technicals & Real-Time Volume Triggers - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Cantor Fitzgerald maintains Overweight rating on Taysha Gene Therapies stock - Investing.com Canada

Nov 14, 2025
pulisher
Nov 14, 2025

Why Taysha Gene Therapies Inc. stock is rated strong buyRate Hike & Precise Swing Trade Entry Alerts - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Taysha Gene Therapies Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo

Nov 13, 2025
$39.16
price down icon 1.10%
$100.48
price down icon 1.00%
$32.03
price up icon 1.10%
$95.99
price down icon 0.77%
biotechnology ONC
$331.27
price down icon 1.95%
$205.04
price down icon 0.84%
자본화:     |  볼륨(24시간):